Murphy Polly A.
SEC CIK 1829248 · EDGAR
BoughtSold
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Dir | M - OptEx | $0.00 | +29.6K | 121.7K | +32% | $0 |
| 2026-06-09 18:25 | 2026-06-05 | CELC | Celcuity Inc. | Murphy Polly A. | Dir | A - Grant | $0.00 | +1,530 | 6,530 | +31% | $0 | |
| A | 2026-05-21 18:30 | 2026-05-18 | AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Dir | P - Purchase | $4.17 | +6,100 | 92.1K | +7% | +$25.4K |
| 2026-05-20 16:15 | 2025-05-18 | AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Dir | P - Purchase | $4.17 | +6,100 | 92.1K | +7% | +$25.4K | |
| D | 2025-06-24 | 2025-06-20 | AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Dir | M - OptEx | $0.00 | +29.6K | 86.0K | +52% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Dir | M - OptEx | $0.00 | +33.1K | 56.4K | +142% | $0 |
| 2022-11-23 | 2022-11-22 | CELC | Celcuity Inc. | Murphy Polly A. | Dir | P - Purchase | $9.68 | +5,000 | 5,000 | New | +$48.4K | |
| 2021-12-21 | 2021-12-20 | AVIR | Atea Pharmaceuticals, Inc. | Murphy Polly A. | Dir | P - Purchase | $8.57 | +12.0K | 23.3K | +106% | +$102.8K |
Purchase Sale Sale after option exercise All abbreviations